[1]
L. A. Wicaksana and E. A. T. H. Sirait, “Evaluating the Effectiveness and Safety of a Shortened Rifapentine-Moxifloxacin Regimen in Treating Drug-Sensitive Pulmonary Tuberculosis: A Systematic Review”, JKM, vol. 15, no. 2, pp. 149–156, Mar. 2026.